Production of anti-CD3/28 expanded CD4⁺ T lymphocytes from HIV-infected patients with different degrees of disease progression

Immunotherapy. 2015;7(7):765-75. doi: 10.2217/imt.15.41. Epub 2015 Aug 7.

Abstract

Aims: CD4+ T lymphocytes from HIV-infected patients with different degrees of disease progression based on CD4 count were expanded in vitro using anti-CD3/28-coated beads.

Materials & methods: Purified CD4+ T lymphocytes from healthy subjects and patients were expanded for 3 weeks. Moreover, the improvement of cell expansion by IL-2 supplementation was also determined.

Results: Expanded CD4+ T lymphocytes from patients had lower fold expansion when compared with healthy subjects. Furthermore, patients with high CD4 counts had higher fold expansion than patients with low CD4 count, and IL-2 supplementation further increased cell expansion.

Conclusions: Anti-CD3/28 activation failed to potently induce expansion of CD4+ T lymphocytes from patients. However, the cell expansion could be improved by IL-2 supplementation.

Keywords: CD4+ T lymphocytes; HIV-infected patients; anti-CD3/28 coated beads; in vitro cell expansion.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Allografts
  • CD28 Antigens
  • CD3 Complex
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / transplantation*
  • Female
  • HIV Infections / immunology
  • HIV Infections / therapy*
  • Humans
  • Lymphocyte Transfusion*
  • Male
  • Middle Aged

Substances

  • CD28 Antigens
  • CD3 Complex